PATENT CLAIM ANALYSIS

Application Number: 15946919
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["607", "044000"]

Abstract:
Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for percutaneous intravascular delivery of pulsed electric fields to achieve such neuromodulation.

Claim (Index 22):
The method of  claim 14  wherein ablating nerves that innervate a kidney of the patient results in a therapeutically beneficial reduction in clinical symptoms of heart failure in the patient.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 91.0
- Lexical Diversity: 1.37313
- Patent Class: 607.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14056888', '15019793', '13619851', '14636317', '12777892']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7622550762357493
- 35 USC 102 Novelty (BERT): 0.6022442184365577
- Combined Prediction Score: 0.7462539904558301
- Mean Citation Score: 578.5250020000002
- Max Citation Score: 629.8292
- Similarity Product: 535.9258297589303

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test